neovascular AMD

BASEL, Switzerland, July 24, 2026 Roche announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use...

TEL AVIV, Israel, June 4, 2026 Teva Pharmaceutical Industries Ltd. has announced the European launch of AHZANTIVE® (aflibercept), an...

RAHWAY, N.J., April 2, 2026 Merck (MSD) has announced the initiation of a pivotal Phase 2b/3 clinical trial (MALBEC)...